364629-87-8

Basic information

• Product Name: Magnesium, bromo(3-bromo-5-methylphenyl)-
• CAS NO: 364629-87-8
• Molecular Formula: C7H6Br2Mg
• Molecular Weight: 274.238
• Mol File: 364629-87-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Magnesium, bromo(3-bromo-5-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Magnesium, bromo(3-bromo-5-methylphenyl)-(364629-87-8)
• EPA Substance Registry System: Magnesium, bromo(3-bromo-5-methylphenyl)-(364629-87-8)

Safety Data

• Hazardous Substances Data: 364629-87-8(Hazardous Substances Data)

Upstream product

• 1611-92-3 3,5-dibromotoluene 
• 7439-95-4 magnesium 

Downstream Products

• 926044-48-6 methyl 1-benzyl-3-(3-bromo5-methyl-phenyl)piperidine-4-carboxylate 
• 239066-82-1 5-(3-bromo-5-methylphenyl)-2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline 

Relevant articles and documents

Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists

The present application describes compounds, including all pharmaceutically acceptable salts, prodrugs, solvates and stereoisomers thereof, according to Formula I, pharmaceutical compositions, comprising at least one compound according to Formula I and optionally at least one additional therapeutic agent and methods of treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using compounds according to Formula I